Physiomics Share Discussion Threads

[pwhite73] 01/5/2018 16:01

It most certainly will if half the people invested in this dog ever find out who he actually is.

[margic] 01/5/2018 15:33

A lot to lose to you might not be a lot to lose to someone else. I have a few clients in a business I still have that could throw a good million or two into something and they wouldn't even feel it leave their pockets. Stigs holding might be big but his life may not depend on it

[obiterdicta] 01/5/2018 13:17

Thank you the stig. Software businesses are more scaleable than service businesses. So have a small shareholding here and may add as and when the business scales up.

OD

[the stigologist] 01/5/2018 13:08

OD

It is a Services sale on the B2B side (similar to companies like Certara and Simulations Plus)



That is why it could be of interest as a target to Certara (owned by a Private Equity/VC player looking to build the Industry Gold standard house but they don't have the segment expertise in Oncology Physiomics possess). They said in the October 2nd 2017 RNS they were in talks with SIX Larger Service Providers who would provide an additional route to market/give them more feet on the ground and hoped to finalise a deal with 1 within six months. Still waiting for conclusion on that.

On the B2C side it has potential to be more of a scaleable software sale if they successfully develop the Cancer DSS tool in association with Oxford Uni and the NHS. This is where they could compete/co-operate with likes of DeepMind/GRAIL

[pwhite73] 01/5/2018 12:58

The only person here who has an agenda is me. That agenda is to warn people not see PYC as some sort of tiddler pharma that can be transformed by a successful drug product or a buy out. They are nothing but a spinoff of a university research laboratory.

They survive solely on government grants, research funding and of course equity placings.

And to be fair to PYC they have never pretended to be anything else.

[billthebank] 01/5/2018 10:43

Smcl So many people on here have an agenda and Stig has made it clear exactly what his is re PYC Nothing hidden.I like that Refreshing.Clearly we have done our research and are invested.I am sure if any prospective investor looks at how this company has moved forward in the last 6 months they will clearly see there is a lot going on and Jim Millen is doing a cracking job

[obiterdicta] 01/5/2018 10:37

The key issue for me is scaleability - how scaleable is the business to ramp up sales without also ramping up staff costs? It seems that they are not selling a product - software - but a service - modelling (very simple summary that). Is this correct or am I missing something?

OD

[smcl] 01/5/2018 10:26

Bill the bank- yes he has acknowledged his holding but you can’t deny that’s a big incentive to ramp and post incessantly.

I’ve been in PYC for a long time am hopeful but not ‘in love’ with the share.

Stig has obvious reasons to be in love with PYC - if it were to fail he has a hell of a lot to lose!

[billthebank] 01/5/2018 10:19

Of course he is positive.He has declared thst he has a large holding so not exactly hiding anything.You can't fault his research can you? IMO the full set of results will tell us more and it will be interesting to see which of our contracts get extended! Can you imagine where this will go if all of them result in more business.Regsrding the grants and the size of the cv that would also have a very positive impact on the share price The company have increased their staffing I believe on the back of last grant and new contracts.zthey had reduced their costs significantly prior to this.I expect this is no longer an issue but full set of results will confirm. Remind me what is the c.v. here? Lots of potential IMO

[the stigologist] 01/5/2018 10:09

Looks like Innovate UK are in funding mode



Cancer immunotherapy research receives £1m Innovate UK funding
30/04/2018

PhoreMost Limited and NeoPhore Limited have announced the companies will receive £1 million of funding to support the development of a novel small-molecule cancer immunotherapy programme, following the award of a Biomedical Catalyst grant in a recent Innovate UK competition.




Biopharma receives grant from Innovate UK to expand model of bacterial cell wall

26 April 2018 11:12

Biopharmaceutical company, Oppilotech, has been awarded with a grant from Innovate UK to expand its computational model of the outer wall of Gram-negative bacteria.

Using a systems biology approach, the company is working on building a detailed, sophisticated, experimentally validated model of the outer wall of bacteria with the ultimate aim of improving understanding of this part of the bacteria and how it can be disrupted.

[smcl] 30/4/2018 22:18

Watch Stig- continually posting because he has a lot invested and therefore a lot to lose.

The market will decide either way not STIG.

CAUTION ADVISED!!

[the stigologist] 30/4/2018 21:58

Blimey, £500 punter Dave having a full on breakdown because a stock he wasn't in but spends all day posting about went up 10%

PMSL

[the stigologist] 30/4/2018 21:41

Hard not to get excited about this chart set up

We know the FUNDAMENTAL potential

We know NEWS is due/overdue on a number of fronts

We know it has a CHART history of spiking into the 100p+ level

[the stigologist] 30/4/2018 18:35

PYC chart is gearing up for a mega move IMO

On a Monday with no news it goes up 10%

As the Hybridan Initiation of Coverage note put it

"Given the revenue multiples above, investors who get in now, at a time when
little upside is priced into the valuation, stand the chance of making a return
a multiple of the current share price."

( Top of page 14 )

[the stigologist] 30/4/2018 16:04

Here is a major NHS discussion document on Personalised Medicine

There are several huge impacts PYC could have just in the dosing and scheduling information their technology can help improve, let alone actually zero-ing in on better treatments/drugs/combinations etc

The NHS spends £15bn a year on drugs alone so a small %improvement in more efficient dosing/scheduling would be worth hundreds of millions a year to them

[the stigologist] 30/4/2018 15:54

DeepMind, the Cancer Research UK Imperial Centre and OPTIMAM
Our partnership with the Cancer Research UK Imperial Centre began in November 2017, when we agreed to collaborate with a consortium of leading clinicians and academics led by the Centre, as well as with the AI health research team at Google, to explore the potential benefits that AI technology could have in identifying signs of breast cancer in mammograms (X-rays of the breasts).

Our goal is to use the latest machine learning technology to carefully analyse historic depersonalised mammograms from around 7,500 women provided by the Cancer Research UK-funded OPTIMAM mammography database at the Royal Surrey County Hospital NHS Foundation Trust. These digital images have been stripped of any information which could be used to identify patients and have been available to research groups around the world for a number of years. Through this research, we hope to investigate whether machine learning technology could more accurately identify signs of breast cancer in mammograms, potentially leading to earlier diagnosis and treatment for patients.

If successful, we hope that this research will improve the quality of reporting of screening mammograms, leading to fewer missed cancers, fewer false alarms and, we hope, ultimately saving lives.

[the stigologist] 30/4/2018 15:53

Anybody want to question PYC are in the right sector at the right time with the right tech and the right approach ?

Just got Google/DeepMind looking to utilise AI working on the Big C as well

[the stigologist] 30/4/2018 15:48

Looks like even £500 Dave has panic bought

He knows the chart has turned and massive news is due here

[the stigologist] 30/4/2018 15:17

You can take it from me a 2.625% shareholder

News is due here
News is overdue here
There is potential for TRANSFORMATIONAL news here
This has previously shown potential to do 1p to 32p in 48 hours. A 3100% move !

How many 'punts' give you that potential ?
How many 'punts' come with 'validation' from the likes of

Merck
Oxford University
UK Government etc etc ?

[the stigologist] 30/4/2018 15:13

£200k doesn't even buy you a house

but for £200k here you can buy 5% of a Company which could genuinely help improve cancer care for untold thousands or millions of people

I know which one I think is a better long term investment, economically, morally, spiritually

At £100m Mkt Cap your £200k investment could be worth £5m

[markth126] 30/4/2018 14:05

I have 1% (not a lie before anyone starts) -

[the stigologist] 30/4/2018 13:53

I have over 2.625% now. I think we should set up a PYC Major Private Shareholder group at some point. If we can get together 5% we can approach PYC management about 'upgrading their brokers'. At 10% we could call an EGM demanding it.

It's either grossly incompetent or negligent on the part of the Brokers to not mention comparitors like Certara Deepmind And GRAIL